New Frontier Corp. (NFC), filed additional documents this morning announcing that they have increased the size of their equity commitments associated with their combination with United Family Health (“UFH”).
Previously, New Frontier had secured a $711 million PIPE (71,148,186 shares at $10.00 per share) to help fund the $1.3 billion purchase price of UFH and provide working capital to the Company. The $711 million PIPE was in addition to the $478 million of cash raised by NFC in its initial public offering and through forward purchase commitments obtained at the time of NFC’s initial public offering of $181 million.
The additional subscription agreement is for up to 2,628,000 additional Class A ordinary shares, also at a purchase price of $10.00 per share, which brings the total number of shares that may be issued to 73,776,186 Class A ordinary shares, or up to approximately $737,761,860 in the aggregate.
As a reminder, New Frontier will be holding their shareholder vote to complete their combination with UHF, next Thursday, December 12th.
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...